BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29205508)

  • 21. Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients.
    Pastuszak-Lewandoska D; Kordiak J; Migdalska-Sęk M; Czarnecka KH; Antczak A; Górski P; Nawrot E; Kiszałkiewicz JM; Domańska D; Brzeziańska-Lasota E
    Respir Res; 2015 Jun; 16(1):76. PubMed ID: 26112163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers.
    Zhang YA; Ma X; Sathe A; Fujimoto J; Wistuba I; Lam S; Yatabe Y; Wang YW; Stastny V; Gao B; Larsen JE; Girard L; Liu X; Song K; Behrens C; Kalhor N; Xie Y; Zhang MQ; Minna JD; Gazdar AF
    J Thorac Oncol; 2016 Mar; 11(3):346-360. PubMed ID: 26725182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review and meta-analysis approach on diagnostic value of MLH1 promoter methylation for head and neck squamous cell carcinoma.
    Li Q; Hong J; Shen Z; Deng H; Shen Y; Wu Z; Zhou C
    Medicine (Baltimore); 2019 Oct; 98(43):e17651. PubMed ID: 31651887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance.
    Grasse S; Lienhard M; Frese S; Kerick M; Steinbach A; Grimm C; Hussong M; Rolff J; Becker M; Dreher F; Schirmer U; Boerno S; Ramisch A; Leschber G; Timmermann B; Grohé C; Lüders H; Vingron M; Fichtner I; Klein S; Odenthal M; Büttner R; Lehrach H; Sültmann H; Herwig R; Schweiger MR
    Genome Med; 2018 Jul; 10(1):55. PubMed ID: 30029672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small suitability of the DLEC1, MLH1 and TUSC4 mRNA expression analysis as potential prognostic or differentiating markers for NSCLC patients in the Polish population.
    Kordiak J; Czarnecka KH; Pastuszak-Lewandoska D; Antczak A; Migdalska-Sęk M; Nawrot E; Domańska-Senderowska D; Kiszałkiewicz J; Brzeziańska-Lasota E
    J Genet; 2017 Jun; 96(2):227-234. PubMed ID: 28674222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Promoter methylation of ASPP1 and ASPP2 genes in non-small cell lung cancers].
    Wei WL; Hu HY; Zhang LJ; Chen Y; Ye E; Wang XF
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):532-6. PubMed ID: 22169642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant frequency of allelic imbalance in 3p region covering RARβ and MLH1 loci seems to be essential in molecular non-small cell lung cancer diagnosis.
    Antczak A; Migdalska-Sęk M; Pastuszak-Lewandoska D; Czarnecka K; Nawrot E; Domańska D; Kordiak J; Górski P; Brzeziańska E
    Med Oncol; 2013 Jun; 30(2):532. PubMed ID: 23504373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.
    Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL
    Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
    Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
    Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.
    Yokoyama T; Takehara K; Sugimoto N; Kaneko K; Fujimoto E; Okazawa-Sakai M; Okame S; Shiroyama Y; Yokoyama T; Teramoto N; Ohsumi S; Saito S; Imai K; Sugano K
    BMC Cancer; 2018 May; 18(1):576. PubMed ID: 29783979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer.
    Liu Z; Zhao J; Chen XF; Li W; Liu R; Lei Z; Liu X; Peng X; Xu K; Chen J; Liu H; Zhou QH; Zhang HT
    Lung Cancer; 2008 Oct; 62(1):15-22. PubMed ID: 18358560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma.
    Do H; Wong NC; Murone C; John T; Solomon B; Mitchell PL; Dobrovic A
    Sci Rep; 2014 Feb; 4():4186. PubMed ID: 24569633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer.
    Zhang X; Yang X; Wang J; Liang T; Gu Y; Yang D
    Int J Clin Exp Pathol; 2015; 8(9):11452-7. PubMed ID: 26617874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation profiling of archived non-small cell lung cancer: a promising prognostic system.
    Safar AM; Spencer H; Su X; Coffey M; Cooney CA; Ratnasinghe LD; Hutchins LF; Fan CY
    Clin Cancer Res; 2005 Jun; 11(12):4400-5. PubMed ID: 15958624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer.
    Wang Z; Chen Z; Gao Y; Li N; Li B; Tan F; Tan X; Lu N; Sun Y; Sun J; Sun N; He J
    Cancer Biol Ther; 2011 Mar; 11(5):490-6. PubMed ID: 21383543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma.
    Kim JS; Han J; Shim YM; Park J; Kim DH
    Cancer; 2005 Nov; 104(9):1825-33. PubMed ID: 16177988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptor expression and gene promoter methylation in non-small cell lung cancer - a short report.
    Tekpli X; Skaug V; Bæra R; Phillips DH; Haugen A; Mollerup S
    Cell Oncol (Dordr); 2016 Dec; 39(6):583-589. PubMed ID: 27572263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of apoptosis-associated speck-like protein containing a CARD gene promoter methylation in resectable non-small-cell lung cancer.
    Zhang Z; Tan S; Zhang L
    Clin Lung Cancer; 2006 Jul; 8(1):62-5. PubMed ID: 16870048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter methylation of APC and RAR-β genes as prognostic markers in non-small cell lung cancer (NSCLC).
    Feng H; Zhang Z; Qing X; Wang X; Liang C; Liu D
    Exp Mol Pathol; 2016 Feb; 100(1):109-13. PubMed ID: 26681652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FHIT promoter methylation status, low protein and high mRNA levels in patients with non-small cell lung cancer.
    Czarnecka KH; Migdalska-Sęk M; Domańska D; Pastuszak-Lewandoska D; Dutkowska A; Kordiak J; Nawrot E; Kiszałkiewicz J; Antczak A; Brzeziańska-Lasota E
    Int J Oncol; 2016 Sep; 49(3):1175-84. PubMed ID: 27572663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.